» Articles » PMID: 2839697

Role of Glycoprotein GIII of Pseudorabies Virus in Virulence

Overview
Journal J Virol
Date 1988 Aug 1
PMID 2839697
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Deletion mutants of pseudorabies virus unable to express glycoprotein gIII, gI, or gp63 or double and triple mutants defective in these glycoproteins were constructed, and their virulence for day-old chickens inoculated intracerebrally was determined. Mutants of wild-type pseudorabies virus defective in glycoprotein gIII, gI, or gp63 were only slightly less virulent (at most, fivefold) for chickens than was the wild-type virus. However, mutants defective in both gIII and gI or gIII and gp63 were avirulent for chickens, despite their ability to grow in cell culture in vitro to about the same extent as mutants defective in gIII alone (which were virulent). These results show that gIII plays a role in virulence and does so in conjunction with gI or gp63. The effect of gIII on virulence was also shown when the resident gIII gene of variants of the Bartha vaccine strain (which codes for gIIIB) was replaced with a gIII gene derived from a virulent wild-type strain (which codes for gIIIKa); gIIIKa significantly enhanced the virulence of a variant of the Bartha strain to which partial virulence had been previously restored by marker rescue. Our results show that viral functions that play a role in the virulence of the virus (as measured by intracerebral inoculation of chickens) may act synergistically to affect the expression of virulence and that the ability of the virus to grow in cell culture is not necessarily correlated with virulence.

Citing Articles

The Attenuated Pseudorabies Virus Vaccine Strain Bartha K61: A Brief Review on the Knowledge Gathered During 60 Years of Research.

Delva J, Nauwynck H, Mettenleiter T, Favoreel H Pathogens. 2020; 9(11).

PMID: 33121171 PMC: 7693725. DOI: 10.3390/pathogens9110897.


Distribution characteristics of DNA vaccine encoded with glycoprotein C from Anatid herpesvirus 1 with chitosan and liposome as deliver carrier in ducks.

Sun K, Li X, Jiang J, Cheng A, Wang M, Zhu D Virol J. 2013; 10:89.

PMID: 23497107 PMC: 3616852. DOI: 10.1186/1743-422X-10-89.


Identification and characterization of duck plague virus glycoprotein C gene and gene product.

Lian B, Xu C, Cheng A, Wang M, Zhu D, Luo Q Virol J. 2010; 7:349.

PMID: 21110887 PMC: 3004831. DOI: 10.1186/1743-422X-7-349.


High-level expression of Marek's disease virus glycoprotein C is detrimental to virus growth in vitro.

Tischer B, Schumacher D, Chabanne-Vautherot D, Zelnik V, Vautherot J, Osterrieder N J Virol. 2005; 79(10):5889-99.

PMID: 15857974 PMC: 1091721. DOI: 10.1128/JVI.79.10.5889-5899.2005.


The porcine humoral immune response against pseudorabies virus specifically targets attachment sites on glycoprotein gC.

Ober B, Teufel B, Wiesmuller K, Jung G, Pfaff E, Saalmuller A J Virol. 2000; 74(4):1752-60.

PMID: 10644346 PMC: 111651. DOI: 10.1128/jvi.74.4.1752-1760.2000.


References
1.
Robbins A, Whealy M, Watson R, Enquist L . Pseudorabies virus gene encoding glycoprotein gIII is not essential for growth in tissue culture. J Virol. 1986; 59(3):635-45. PMC: 253225. DOI: 10.1128/JVI.59.3.635-645.1986. View

2.
Lomniczi B, Watanabe S, Ben-Porat T, Kaplan A . Genome location and identification of functions defective in the Bartha vaccine strain of pseudorabies virus. J Virol. 1987; 61(3):796-801. PMC: 254022. DOI: 10.1128/JVI.61.3.796-801.1987. View

3.
Petrovskis E, Timmins J, Gierman T, Post L . Deletions in vaccine strains of pseudorabies virus and their effect on synthesis of glycoprotein gp63. J Virol. 1986; 60(3):1166-9. PMC: 253379. DOI: 10.1128/JVI.60.3.1166-1169.1986. View

4.
Thompson R, Stevens J . Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology. 1983; 131(1):171-9. DOI: 10.1016/0042-6822(83)90543-3. View

5.
Kumel G, KAERNER H, Levine M, Schroder C, Glorioso J . Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity. J Virol. 1985; 56(3):930-7. PMC: 252666. DOI: 10.1128/JVI.56.3.930-937.1985. View